Global CRO Mass Spectroscopy Services Market By Service Type (Targeted Proteomics, Biologics characterization, Metabolomics, Multi-omics services, Glycomics Services, Others) By End Users (Research Centers, Biopharmaceutical and Pharmaceutical companies, Medical Device Companies, Clinical Diagnostics, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Pharmaceutical and biopharmaceutical firms are putting a greater emphasis on the development of innovative drugs for the management of various chronic illnesses. Over time, there has been a significant rise in the approval rate of new drugs, which has led to outsourcing of research and development activities. Additionally, CRO mass spectroscopy service providers are using advanced mass spectrometers with increased sensitivity and resolution of the instrument which has opened new dimensions in analysis of pharmaceuticals and complex metabolites of biological systems. For instance, in June 2020, low-flow LC-MS/MS was introduced by Alturas Analytics, Inc., to enhance operational functionality. Due to its better sensitivity and dynamic diversity, the business chose to incorporate an OptiFlow ion source designed for microflow of SCIEX Triple Quad 7500 LC-MS/MS systems, the QTRAP Ready, for this application. Over the past ten years, the global pharmaceutical industry's innovation environment has seen a significant transformation. Pharmaceutical businesses are focused on enhancing and accelerating in order to raise drug-discovery programme success rates and lower R&D expenses. There has been a rise in significant partnerships for outsourcing mass spectroscopy to contract research organisations (CROs) to assist research and development efforts for quick testing which proves to be crucial. For instance, to expand its operations in San Francisco and Boston, Charles River Laboratories (CRL), a top pharmaceutical firm, inked a USD 295 million agreement with Explora Biolabs, a major supplier of contract vivarium research facilities, in April 2022. Thus with mergers and acquisitions along advancements, the CRO mass spectroscopy services market is experiencing a huge growth.
In terms of revenue, global CRO mass spectroscopy services market was valued at US$ 621.10 Mn in 2021 growing at a CAGR of 16.79 over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global CRO Mass Spectroscopy Services Market Revenue & Forecast, (US$ Million), 2015 – 2030
Service Type Outlook:
Based service type, the CRO mass spectroscopy services market is segmented into targeted proteomics, biologics characterization, metabolomics, multi-omics services, glycomics services and others. Metabolomics is estimated to be the fastest growing segment with a CAGR of 16.89% and a revenue of USD 594.18 Million by 2030. Metabolomics with a mass spectrometry framework has been used to several disease study fields. The discovery and identification of metabolite biomarkers is greatly aided by the combination of metabolomics and mass spectrometry. The biological sciences' exploratory research might be enhanced and developed using the mass spectrometry technique.
End Users Outlook:
Based on end users segment the market is segmented into research centers, biopharmaceutical and pharmaceutical companies, medical device companies, clinical diagnostics and others. Biopharmaceutical and pharmaceutical companies had the highest share in the CRO mass spectroscopy services market in the year 2021. The CRO mass spectroscopy services market has been expanding consistently. It has benefitted from current advanced technologies as well as expanding R&D pipelines in the pharmaceutical industry and the rise of smaller medication manufacturers. The contract research organizations are incorporating advanced mass spectroscopy services and instruments to cater the rising demand. For instance The Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology was recently acquired by Waters Corporation from MediMass Ltd. The iKnife, or Intelligent Knife, is a device that is currently in the conceptual stages of development that will enable mass spectrometry to play a larger role in clinical diagnostic research.
Region Outlook:
Based on region, Asia Pacific region is anticipated to be the fastest growing region in CRO mass spectroscopy services market. It is estimated that by 2030, the Asia Pacific region will reach a CAGR of 17.19% with a revenue of USD 553.50 Million. Mass spectroscopy technology is advancing at an incredible rate, both in terms of speed and resolution. While the leading players in the Asia Pacific region are focused on the expansion of possible application areas is fueled by the addition of new tools and software. These considerations are encouraging the expanding use of mass spectroscopy in many different sectors, including drug discovery, proteomics, pharmaceuticals, and food safety monitoring. Moreover leading players in the market are looking forward to mergers and acquisitions to expand their global presence as well as widen their service offerings for mass spectroscopy across a wide range of application. Thus with above factors mentioned the Asia Pacific region is expected to flourish during the forecast period 2022-2030.
Competitive Landscape
The report provides both, qualitative and quantitative research of global CRO mass spectroscopy services market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the CRO mass spectroscopy services market are listed:
- Alphalyse
- Altasciences
- AxisPharm
- Alturas Analytics
- BGI
- biocrates inc.
- Biognosys Inc
- Biolabs Inc.
- Charles River Laboratories
- Creative Proteomics.
- Evotec SE
- LiVeritas Biosciences, Inc.
- MS Bioworks
- Novatia, LLC
- PPD Inc.
- Protagen Protein Services GmbH
- NorthEast BioAnalytical Laboratories LLC
- Waters Corporation
- Other Industry Participants
Global CRO Mass Spectroscopy Services Market:
By Service Type
- Targeted Proteomics
- Biologics characterization
- Metabolomics
- Multi-omics services
- Glycomics Services
- Others
By End Users
- Research Centers
- Biopharmaceutical and Pharmaceutical companies
- Medical Device Companies
- Clinical Diagnostics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of CRO Mass Spectroscopy Services
Market
6.
Market
Synopsis: CRO Mass Spectroscopy
Services Market
7.
CRO
Mass Spectroscopy Services Market
Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in CRO Mass Spectroscopy Services Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
CRO Mass Spectroscopy Services Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on CRO Mass Spectroscopy
Services Market
8.
Global
CRO Mass Spectroscopy Services Market
Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global CRO Mass Spectroscopy Services Market Revenue (US$ Mn)
8.2. Global CRO Mass Spectroscopy Services Market Revenue (US$ Mn) and Forecasts, By
Service Type
8.2.1. Targeted Proteomics
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 – 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1.
Market
Estimation, 2015 - 2021
8.2.1.5.1.2.
Market
Forecast, 2022 – 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1.
Market
Estimation, 2015 - 2021
8.2.1.5.2.2.
Market
Forecast, 2022 – 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1.
Market
Estimation, 2015 - 2021
8.2.1.5.3.2.
Market
Forecast, 2022 – 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1.
Market
Estimation, 2015 - 2021
8.2.1.5.4.2.
Market
Forecast, 2022 – 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1.
Market
Estimation, 2015 - 2021
8.2.1.5.5.2.
Market
Forecast, 2022 – 2030
8.2.2. Biologics characterization
8.2.2.1.
Definition
8.2.2.2.
Market Estimation
and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 – 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1.
Market
Estimation, 2015 - 2021
8.2.2.5.1.2.
Market
Forecast, 2022 – 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1.
Market
Estimation, 2015 - 2021
8.2.2.5.2.2.
Market
Forecast, 2022 – 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1.
Market
Estimation, 2015 - 2021
8.2.2.5.3.2.
Market
Forecast, 2022 – 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1.
Market
Estimation, 2015 - 2021
8.2.2.5.4.2.
Market
Forecast, 2022 – 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1.
Market
Estimation, 2015 - 2021
8.2.2.5.5.2.
Market
Forecast, 2022 – 2030
8.2.3. Metabolomics
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.3.3.
Market
Forecast, 2022 – 2030
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1.
Market
Estimation, 2015 - 2021
8.2.3.5.1.2.
Market
Forecast, 2022 – 2030
8.2.3.5.2.
Europe
8.2.3.5.2.1.
Market
Estimation, 2015 - 2021
8.2.3.5.2.2.
Market
Forecast, 2022 – 2030
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1.
Market
Estimation, 2015 - 2021
8.2.3.5.3.2.
Market
Forecast, 2022 – 2030
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1.
Market
Estimation, 2015 - 2021
8.2.3.5.4.2.
Market
Forecast, 2022 – 2030
8.2.3.5.5.
Latin
America
8.2.3.5.5.1.
Market
Estimation, 2015 - 2021
8.2.3.5.5.2.
Market
Forecast, 2022 – 2030
8.2.4. Multi-omics services
8.2.4.1.
Definition
8.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.4.3.
Market
Forecast, 2022 – 2030
8.2.4.4.
Compound
Annual Growth Rate (CAGR)
8.2.4.5.
Regional
Bifurcation
8.2.4.5.1.
North
America
8.2.4.5.1.1.
Market
Estimation, 2015 - 2021
8.2.4.5.1.2.
Market
Forecast, 2022 – 2030
8.2.4.5.2.
Europe
8.2.4.5.2.1.
Market
Estimation, 2015 - 2021
8.2.4.5.2.2.
Market
Forecast, 2022 – 2030
8.2.4.5.3.
Asia
Pacific
8.2.4.5.3.1.
Market
Estimation, 2015 - 2021
8.2.4.5.3.2.
Market
Forecast, 2022 – 2030
8.2.4.5.4.
Middle
East and Africa
8.2.4.5.4.1.
Market
Estimation, 2015 - 2021
8.2.4.5.4.2.
Market
Forecast, 2022 – 2030
8.2.4.5.5.
Latin
America
8.2.4.5.5.1.
Market
Estimation, 2015 - 2021
8.2.4.5.5.2.
Market
Forecast, 2022 – 2030
8.2.5. Glycomics Services
8.2.5.1.
Definition
8.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.5.3.
Market
Forecast, 2022 – 2030
8.2.5.4.
Compound
Annual Growth Rate (CAGR)
8.2.5.5.
Regional
Bifurcation
8.2.5.5.1.
North
America
8.2.5.5.1.1.
Market
Estimation, 2015 - 2021
8.2.5.5.1.2.
Market
Forecast, 2022 – 2030
8.2.5.5.2.
Europe
8.2.5.5.2.1.
Market
Estimation, 2015 - 2021
8.2.5.5.2.2.
Market
Forecast, 2022 – 2030
8.2.5.5.3.
Asia
Pacific
8.2.5.5.3.1.
Market
Estimation, 2015 - 2021
8.2.5.5.3.2.
Market
Forecast, 2022 – 2030
8.2.5.5.4.
Middle
East and Africa
8.2.5.5.4.1.
Market
Estimation, 2015 - 2021
8.2.5.5.4.2.
Market
Forecast, 2022 – 2030
8.2.5.5.5.
Latin
America
8.2.5.5.5.1.
Market
Estimation, 2015 - 2021
8.2.5.5.5.2.
Market
Forecast, 2022 – 2030
8.2.6. Others
8.2.6.1.
Definition
8.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.6.3.
Market
Forecast, 2022 – 2030
8.2.6.4.
Compound
Annual Growth Rate (CAGR)
8.2.6.5.
Regional
Bifurcation
8.2.6.5.1.
North
America
8.2.6.5.1.1.
Market
Estimation, 2015 - 2021
8.2.6.5.1.2.
Market
Forecast, 2022 – 2030
8.2.6.5.2.
Europe
8.2.6.5.2.1.
Market
Estimation, 2015 - 2021
8.2.6.5.2.2.
Market
Forecast, 2022 – 2030
8.2.6.5.3.
Asia
Pacific
8.2.6.5.3.1.
Market
Estimation, 2015 - 2021
8.2.6.5.3.2.
Market
Forecast, 2022 – 2030
8.2.6.5.4.
Middle
East and Africa
8.2.6.5.4.1.
Market
Estimation, 2015 - 2021
8.2.6.5.4.2.
Market
Forecast, 2022 – 2030
8.2.6.5.5.
Latin
America
8.2.6.5.5.1.
Market
Estimation, 2015 - 2021
8.2.6.5.5.2.
Market
Forecast, 2022 – 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Service Type
9.
Global
CRO Mass Spectroscopy Services Market
Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global CRO Mass Spectroscopy Services Market Revenue (US$ Mn) and Forecasts, By End
Users
9.2.1. Research Centers Medical Device Companies
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 – 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1.
Market
Estimation, 2015 - 2021
9.2.1.5.1.2.
Market
Forecast, 2022 – 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1.
Market
Estimation, 2015 - 2021
9.2.1.5.2.2.
Market
Forecast, 2022 – 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1.
Market
Estimation, 2015 - 2021
9.2.1.5.3.2.
Market
Forecast, 2022 – 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1.
Market
Estimation, 2015 - 2021
9.2.1.5.4.2.
Market
Forecast, 2022 – 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1.
Market
Estimation, 2015 - 2021
9.2.1.5.5.2.
Market
Forecast, 2022 – 2030
9.2.2. Biopharmaceutical and Pharmaceutical
companies
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 – 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1.
Market
Estimation, 2015 - 2021
9.2.2.5.1.2.
Market
Forecast, 2022 – 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1.
Market
Estimation, 2015 - 2021
9.2.2.5.2.2.
Market
Forecast, 2022 – 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1.
Market
Estimation, 2015 - 2021
9.2.2.5.3.2.
Market
Forecast, 2022 – 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1.
Market
Estimation, 2015 - 2021
9.2.2.5.4.2.
Market
Forecast, 2022 – 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1.
Market
Estimation, 2015 - 2021
9.2.2.5.5.2.
Market
Forecast, 2022 – 2030
9.2.3. Medical Device Companies
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 – 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1.
Market
Estimation, 2015 - 2021
9.2.3.5.1.2.
Market
Forecast, 2022 – 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1.
Market
Estimation, 2015 - 2021
9.2.3.5.2.2.
Market
Forecast, 2022 – 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1.
Market
Estimation, 2015 - 2021
9.2.3.5.3.2.
Market
Forecast, 2022 – 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1.
Market
Estimation, 2015 - 2021
9.2.3.5.4.2.
Market
Forecast, 2022 – 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1.
Market
Estimation, 2015 - 2021
9.2.3.5.5.2.
Market
Forecast, 2022 – 2030
9.2.4. Clinical Diagnostics
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.4.3.
Market
Forecast, 2022 – 2030
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1.
Market
Estimation, 2015 - 2021
9.2.4.5.1.2.
Market
Forecast, 2022 – 2030
9.2.4.5.2.
Europe
9.2.4.5.2.1.
Market
Estimation, 2015 - 2021
9.2.4.5.2.2.
Market
Forecast, 2022 – 2030
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1.
Market
Estimation, 2015 - 2021
9.2.4.5.3.2.
Market
Forecast, 2022 – 2030
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1.
Market
Estimation, 2015 - 2021
9.2.4.5.4.2.
Market
Forecast, 2022 – 2030
9.2.4.5.5.
Latin
America
9.2.4.5.5.1.
Market
Estimation, 2015 - 2021
9.2.4.5.5.2.
Market
Forecast, 2022 – 2030
9.2.5. Others
9.2.5.1.
Definition
9.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.5.3.
Market
Forecast, 2022 – 2030
9.2.5.4.
Compound
Annual Growth Rate (CAGR)
9.2.5.5.
Regional
Bifurcation
9.2.5.5.1.
North America
9.2.5.5.1.1.
Market
Estimation, 2015 - 2021
9.2.5.5.1.2.
Market
Forecast, 2022 – 2030
9.2.5.5.2.
Europe
9.2.5.5.2.1.
Market
Estimation, 2015 - 2021
9.2.5.5.2.2.
Market
Forecast, 2022 – 2030
9.2.5.5.3.
Asia
Pacific
9.2.5.5.3.1.
Market
Estimation, 2015 - 2021
9.2.5.5.3.2.
Market
Forecast, 2022 – 2030
9.2.5.5.4.
Middle
East and Africa
9.2.5.5.4.1.
Market
Estimation, 2015 - 2021
9.2.5.5.4.2.
Market
Forecast, 2022 – 2030
9.2.5.5.5.
Latin
America
9.2.5.5.5.1.
Market
Estimation, 2015 - 2021
9.2.5.5.5.2.
Market
Forecast, 2022 – 2030
9.3. Key Segment for Channeling Investments
9.3.1. By End Users
10. North America CRO Mass Spectroscopy
Services Market Analysis and Forecasts, 2022
– 2030
10.1. Overview
10.1.1. North America CRO Mass Spectroscopy
Services Market Revenue (US$ Mn)
10.2. North America CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By Service Type
10.2.1. Targeted Proteomics
10.2.2. Biologics characterization
10.2.3. Metabolomics
10.2.4. Multi-omics services
10.2.5. Glycomics Services
10.2.6. Others
10.3. North America CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By End Users
10.3.1. Research Centers Medical Device Companies
10.3.2. Biopharmaceutical and Pharmaceutical
companies
10.3.3. Medical Device Companies
10.3.4. Clinical Diagnostics
10.3.5. Others
10.4. North America CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By Country
10.4.1. U.S
10.4.1.1.
U.S CRO
Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
10.4.1.1.1.
Targeted
Proteomics
10.4.1.1.2.
Biologics
characterization
10.4.1.1.3.
Metabolomics
10.4.1.1.4.
Multi-omics services
10.4.1.1.5.
Glycomics
Services
10.4.1.1.6.
Others
10.4.1.2.
U.S CRO
Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
10.4.1.2.1.
Research
Centers Medical Device Companies
10.4.1.2.2.
Biopharmaceutical
and Pharmaceutical companies
10.4.1.2.3.
Medical
Device Companies
10.4.1.2.4.
Clinical
Diagnostics
10.4.1.2.5.
Others
10.4.2. Canada
10.4.2.1.
Canada
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
10.4.2.1.1.
Targeted
Proteomics
10.4.2.1.2.
Biologics
characterization
10.4.2.1.3.
Metabolomics
10.4.2.1.4.
Multi-omics services
10.4.2.1.5.
Glycomics
Services
10.4.2.1.6.
Others
10.4.2.2.
Canada
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
10.4.2.2.1.
Research
Centers Medical Device Companies
10.4.2.2.2.
Biopharmaceutical
and Pharmaceutical companies
10.4.2.2.3.
Medical
Device Companies
10.4.2.2.4.
Clinical
Diagnostics
10.4.2.2.5.
Others
10.4.3. Mexico
10.4.3.1.
Mexico
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
10.4.3.1.1.
Targeted
Proteomics
10.4.3.1.2.
Biologics
characterization
10.4.3.1.3.
Metabolomics
10.4.3.1.4.
Multi-omics services
10.4.3.1.5.
Glycomics
Services
10.4.3.1.6.
Others
10.4.3.2.
Mexico
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
10.4.3.2.1.
Research
Centers Medical Device Companies
10.4.3.2.2.
Biopharmaceutical
and Pharmaceutical companies
10.4.3.2.3.
Medical
Device Companies
10.4.3.2.4.
Clinical
Diagnostics
10.4.3.2.5.
Others
10.4.4. Rest of North America
10.4.4.1.
Rest of
North America CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
10.4.4.1.1.
Targeted
Proteomics
10.4.4.1.2.
Biologics
characterization
10.4.4.1.3.
Metabolomics
10.4.4.1.4.
Multi-omics services
10.4.4.1.5.
Glycomics
Services
10.4.4.1.6.
Others
10.4.4.2.
Rest of
North America CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By End Users
10.4.4.2.1.
Research
Centers Medical Device Companies
10.4.4.2.2.
Biopharmaceutical
and Pharmaceutical companies
10.4.4.2.3.
Medical
Device Companies
10.4.4.2.4.
Clinical
Diagnostics
10.4.4.2.5.
Others
10.5. Key Segment for Channeling Investments
10.5.1. By Country
10.5.2. By Service Type
10.5.3. By End Users
11. Europe CRO Mass Spectroscopy Services Market Analysis and Forecasts, 2022 – 2030
11.1. Overview
11.1.1. Europe CRO Mass Spectroscopy Services Market Revenue (US$ Mn)
11.2. Europe CRO Mass Spectroscopy Services Market Revenue (US$ Mn) and Forecasts, By
Service Type
11.2.1. Targeted Proteomics
11.2.2. Biologics characterization
11.2.3. Metabolomics
11.2.4. Multi-omics services
11.2.5. Glycomics Services
11.2.6. Others
11.3. Europe CRO Mass Spectroscopy Services Market Revenue (US$ Mn) and Forecasts, By End
Users
11.3.1. Research Centers Medical Device Companies
11.3.2. Biopharmaceutical and Pharmaceutical
companies
11.3.3. Medical Device Companies
11.3.4. Clinical Diagnostics
11.3.5. Others
11.4. Europe CRO Mass Spectroscopy Services Market Revenue (US$ Mn) and Forecasts, By
Country
11.4.1. France
11.4.1.1.
France
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
11.4.1.1.1.
Targeted
Proteomics
11.4.1.1.2.
Biologics
characterization
11.4.1.1.3.
Metabolomics
11.4.1.1.4.
Multi-omics services
11.4.1.1.5.
Glycomics
Services
11.4.1.1.6.
Others
11.4.1.2.
France
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
11.4.1.2.1.
Research
Centers Medical Device Companies
11.4.1.2.2.
Biopharmaceutical
and Pharmaceutical companies
11.4.1.2.3.
Medical
Device Companies
11.4.1.2.4.
Clinical
Diagnostics
11.4.1.2.5.
Others
11.4.2. The UK
11.4.2.1.
The UK
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
11.4.2.1.1.
Targeted
Proteomics
11.4.2.1.2.
Biologics
characterization
11.4.2.1.3.
Metabolomics
11.4.2.1.4.
Multi-omics services
11.4.2.1.5.
Glycomics
Services
11.4.2.1.6.
Others
11.4.2.2.
The UK
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
11.4.2.2.1.
Research
Centers Medical Device Companies
11.4.2.2.2.
Biopharmaceutical
and Pharmaceutical companies
11.4.2.2.3.
Medical
Device Companies
11.4.2.2.4.
Clinical
Diagnostics
11.4.2.2.5.
Others
11.4.3. Spain
11.4.3.1.
Spain
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
11.4.3.1.1.
Targeted
Proteomics
11.4.3.1.2.
Biologics
characterization
11.4.3.1.3.
Metabolomics
11.4.3.1.4.
Multi-omics services
11.4.3.1.5.
Glycomics
Services
11.4.3.1.6.
Others
11.4.3.2.
Spain
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
11.4.3.2.1.
Research
Centers Medical Device Companies
11.4.3.2.2.
Biopharmaceutical
and Pharmaceutical companies
11.4.3.2.3.
Medical
Device Companies
11.4.3.2.4.
Clinical
Diagnostics
11.4.3.2.5.
Others
11.4.4. Germany
11.4.4.1.
Germany
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
11.4.4.1.1.
Targeted
Proteomics
11.4.4.1.2.
Biologics
characterization
11.4.4.1.3.
Metabolomics
11.4.4.1.4.
Multi-omics services
11.4.4.1.5.
Glycomics
Services
11.4.4.1.6.
Others
11.4.4.2.
Germany
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
11.4.4.2.1.
Research
Centers Medical Device Companies
11.4.4.2.2.
Biopharmaceutical
and Pharmaceutical companies
11.4.4.2.3.
Medical
Device Companies
11.4.4.2.4.
Clinical
Diagnostics
11.4.4.2.5.
Others
11.4.5. Italy
11.4.5.1.
Italy
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
11.4.5.1.1.
Targeted
Proteomics
11.4.5.1.2.
Biologics
characterization
11.4.5.1.3.
Metabolomics
11.4.5.1.4.
Multi-omics services
11.4.5.1.5.
Glycomics
Services
11.4.5.1.6.
Others
11.4.5.2.
Italy
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
11.4.5.2.1.
Research
Centers Medical Device Companies
11.4.5.2.2.
Biopharmaceutical
and Pharmaceutical companies
11.4.5.2.3.
Medical
Device Companies
11.4.5.2.4.
Clinical
Diagnostics
11.4.5.2.5.
Others
11.4.6. Nordic Countries
11.4.6.1.
Nordic
Countries CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
11.4.6.1.1.
Targeted
Proteomics
11.4.6.1.2.
Biologics
characterization
11.4.6.1.3.
Metabolomics
11.4.6.1.4.
Multi-omics services
11.4.6.1.5.
Glycomics
Services
11.4.6.1.6.
Others
11.4.6.2.
Nordic
Countries CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By End Users
11.4.6.2.1.
Research
Centers Medical Device Companies
11.4.6.2.2.
Biopharmaceutical
and Pharmaceutical companies
11.4.6.2.3.
Medical
Device Companies
11.4.6.2.4.
Clinical
Diagnostics
11.4.6.2.5.
Others
11.4.6.3.
Nordic
Countries CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Country
11.4.6.3.1.
Denmark
11.4.6.3.2.
Finland
11.4.6.3.3.
Iceland
11.4.6.3.4.
Sweden
11.4.6.3.5.
Norway
11.4.7. Benelux Union
11.4.7.1.
Benelux
Union CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
11.4.7.1.1.
Targeted
Proteomics
11.4.7.1.2.
Biologics
characterization
11.4.7.1.3.
Metabolomics
11.4.7.1.4.
Multi-omics services
11.4.7.1.5.
Glycomics
Services
11.4.7.1.6.
Others
11.4.7.2.
Benelux
Union CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By End Users
11.4.7.2.1.
Research
Centers Medical Device Companies
11.4.7.2.2.
Biopharmaceutical
and Pharmaceutical companies
11.4.7.2.3.
Medical
Device Companies
11.4.7.2.4.
Clinical
Diagnostics
11.4.7.2.5.
Others
11.4.7.3.
Benelux
Union CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Country
11.4.7.3.1.
Belgium
11.4.7.3.2.
The
Netherlands
11.4.7.3.3.
Luxembourg
11.4.8. Rest of Europe
11.4.8.1.
Rest of
Europe CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
11.4.8.1.1.
Targeted
Proteomics
11.4.8.1.2.
Biologics
characterization
11.4.8.1.3.
Metabolomics
11.4.8.1.4.
Multi-omics services
11.4.8.1.5.
Glycomics
Services
11.4.8.1.6.
Others
11.4.8.2.
Rest of
Europe CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By End Users
11.4.8.2.1.
Research
Centers Medical Device Companies
11.4.8.2.2.
Biopharmaceutical
and Pharmaceutical companies
11.4.8.2.3.
Medical
Device Companies
11.4.8.2.4.
Clinical
Diagnostics
11.4.8.2.5.
Others
11.5. Key Segment for Channeling Investments
11.5.1. By Country
11.5.2. By Service Type
11.5.3. By End Users
12. Asia Pacific CRO Mass Spectroscopy
Services Market Analysis and Forecasts, 2022
– 2030
12.1. Overview
12.1.1. Asia Pacific CRO Mass Spectroscopy
Services Market Revenue (US$ Mn)
12.2. Asia Pacific CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By Service Type
12.2.1. Targeted Proteomics
12.2.2. Biologics characterization
12.2.3. Metabolomics
12.2.4. Multi-omics services
12.2.5. Glycomics Services
12.2.6. Others
12.3. Asia Pacific CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By End Users
12.3.1. Research Centers Medical Device Companies
12.3.2. Biopharmaceutical and Pharmaceutical
companies
12.3.3. Medical Device Companies
12.3.4. Clinical Diagnostics
12.3.5. Others
12.4. Asia Pacific CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By Country
12.4.1. China
12.4.1.1.
China CRO
Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
12.4.1.1.1.
Targeted
Proteomics
12.4.1.1.2.
Biologics
characterization
12.4.1.1.3.
Metabolomics
12.4.1.1.4.
Multi-omics services
12.4.1.1.5.
Glycomics
Services
12.4.1.1.6.
Others
12.4.1.2.
China
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
12.4.1.2.1.
Research
Centers Medical Device Companies
12.4.1.2.2.
Biopharmaceutical
and Pharmaceutical companies
12.4.1.2.3.
Medical
Device Companies
12.4.1.2.4.
Clinical
Diagnostics
12.4.1.2.5.
Others
12.4.2. Japan
12.4.2.1.
Japan
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
12.4.2.1.1.
Targeted
Proteomics
12.4.2.1.2.
Biologics
characterization
12.4.2.1.3.
Metabolomics
12.4.2.1.4.
Multi-omics services
12.4.2.1.5.
Glycomics
Services
12.4.2.1.6.
Others
12.4.2.2.
Japan
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
12.4.2.2.1.
Research
Centers Medical Device Companies
12.4.2.2.2.
Biopharmaceutical
and Pharmaceutical companies
12.4.2.2.3.
Medical
Device Companies
12.4.2.2.4.
Clinical
Diagnostics
12.4.2.2.5.
Others
12.4.3. India
12.4.3.1.
India
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
12.4.3.1.1.
Targeted
Proteomics
12.4.3.1.2.
Biologics
characterization
12.4.3.1.3.
Metabolomics
12.4.3.1.4.
Multi-omics services
12.4.3.1.5.
Glycomics
Services
12.4.3.1.6.
Others
12.4.3.2.
India
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
12.4.3.2.1.
Research
Centers Medical Device Companies
12.4.3.2.2.
Biopharmaceutical
and Pharmaceutical companies
12.4.3.2.3.
Medical
Device Companies
12.4.3.2.4.
Clinical
Diagnostics
12.4.3.2.5.
Others
12.4.4. New Zealand
12.4.4.1.
New
Zealand CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
12.4.4.1.1.
Targeted
Proteomics
12.4.4.1.2.
Biologics
characterization
12.4.4.1.3.
Metabolomics
12.4.4.1.4.
Multi-omics services
12.4.4.1.5.
Glycomics
Services
12.4.4.1.6.
Others
12.4.4.2.
New
Zealand CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By End Users
12.4.4.2.1.
Research
Centers Medical Device Companies
12.4.4.2.2.
Biopharmaceutical
and Pharmaceutical companies
12.4.4.2.3.
Medical
Device Companies
12.4.4.2.4.
Clinical
Diagnostics
12.4.4.2.5.
Others
12.4.5. Australia
12.4.5.1.
Australia
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
12.4.5.1.1.
Targeted
Proteomics
12.4.5.1.2.
Biologics
characterization
12.4.5.1.3.
Metabolomics
12.4.5.1.4.
Multi-omics services
12.4.5.1.5.
Glycomics
Services
12.4.5.1.6.
Others
12.4.5.2.
Australia
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
12.4.5.2.1.
Research
Centers Medical Device Companies
12.4.5.2.2.
Biopharmaceutical
and Pharmaceutical companies
12.4.5.2.3.
Medical
Device Companies
12.4.5.2.4.
Clinical
Diagnostics
12.4.5.2.5.
Others
12.4.6. South Korea
12.4.6.1.
South
Korea CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
12.4.6.1.1.
Targeted
Proteomics
12.4.6.1.2.
Biologics
characterization
12.4.6.1.3.
Metabolomics
12.4.6.1.4.
Multi-omics services
12.4.6.1.5.
Glycomics
Services
12.4.6.1.6.
Others
12.4.6.2.
South
Korea CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
12.4.6.2.1.
Research
Centers Medical Device Companies
12.4.6.2.2.
Biopharmaceutical
and Pharmaceutical companies
12.4.6.2.3.
Medical
Device Companies
12.4.6.2.4.
Clinical
Diagnostics
12.4.6.2.5.
Others
12.4.7. Southeast Asia
12.4.7.1.
Southeast
Asia CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
12.4.7.1.1.
Targeted
Proteomics
12.4.7.1.2.
Biologics
characterization
12.4.7.1.3.
Metabolomics
12.4.7.1.4.
Multi-omics services
12.4.7.1.5.
Glycomics
Services
12.4.7.1.6.
Others
12.4.7.2.
Southeast
Asia CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By End Users
12.4.7.2.1.
Research
Centers Medical Device Companies
12.4.7.2.2.
Biopharmaceutical
and Pharmaceutical companies
12.4.7.2.3.
Medical
Device Companies
12.4.7.2.4.
Clinical
Diagnostics
12.4.7.2.5.
Others
12.4.7.3.
Southeast
Asia CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Country
12.4.7.3.1.
Indonesia
12.4.7.3.2.
Thailand
12.4.7.3.3.
Malaysia
12.4.7.3.4.
Singapore
12.4.7.3.5.
Rest of
Southeast Asia
12.4.8. Rest of Asia Pacific
12.4.8.1.
Rest of
Asia Pacific CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
12.4.8.1.1.
Targeted
Proteomics
12.4.8.1.2.
Biologics
characterization
12.4.8.1.3.
Metabolomics
12.4.8.1.4.
Multi-omics services
12.4.8.1.5.
Glycomics
Services
12.4.8.1.6.
Others
12.4.8.2.
Rest of
Asia Pacific CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By End Users
12.4.8.2.1.
Research
Centers Medical Device Companies
12.4.8.2.2.
Biopharmaceutical
and Pharmaceutical companies
12.4.8.2.3.
Medical
Device Companies
12.4.8.2.4.
Clinical
Diagnostics
12.4.8.2.5.
Others
12.5. Key Segment for Channeling Investments
12.5.1. By Country
12.5.2. By Service Type
12.5.3. By End Users
13. Middle East and Africa CRO Mass Spectroscopy
Services Market Analysis and Forecasts, 2022
– 2030
13.1. Overview
13.1.1. Middle East and Africa CRO Mass Spectroscopy
Services Market Revenue (US$ Mn)
13.2. Middle East and Africa CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By Service Type
13.2.1. Targeted Proteomics
13.2.2. Biologics characterization
13.2.3. Metabolomics
13.2.4. Multi-omics
services
13.2.5. Glycomics Services
13.2.6. Others
13.3. Middle East and Africa CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By End Users
13.3.1. Research Centers Medical Device Companies
13.3.2. Biopharmaceutical and Pharmaceutical
companies
13.3.3. Medical Device Companies
13.3.4. Clinical Diagnostics
13.3.5. Others
13.4. Middle East and Africa CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By Country
13.4.1. Saudi Arabia
13.4.1.1.
Saudi
Arabia CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
13.4.1.1.1.
Targeted
Proteomics
13.4.1.1.2.
Biologics
characterization
13.4.1.1.3.
Metabolomics
13.4.1.1.4.
Multi-omics services
13.4.1.1.5.
Glycomics
Services
13.4.1.1.6.
Others
13.4.1.2.
Saudi
Arabia CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By End Users
13.4.1.2.1.
Research
Centers Medical Device Companies
13.4.1.2.2.
Biopharmaceutical
and Pharmaceutical companies
13.4.1.2.3.
Medical
Device Companies
13.4.1.2.4.
Clinical
Diagnostics
13.4.1.2.5.
Others
13.4.2. UAE
13.4.2.1.
UAE CRO
Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
13.4.2.1.1.
Targeted
Proteomics
13.4.2.1.2.
Biologics
characterization
13.4.2.1.3.
Metabolomics
13.4.2.1.4.
Multi-omics services
13.4.2.1.5.
Glycomics
Services
13.4.2.1.6.
Others
13.4.2.2.
UAE CRO
Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
13.4.2.2.1.
Research
Centers Medical Device Companies
13.4.2.2.2.
Biopharmaceutical
and Pharmaceutical companies
13.4.2.2.3.
Medical
Device Companies
13.4.2.2.4.
Clinical
Diagnostics
13.4.2.2.5.
Others
13.4.3. Egypt
13.4.3.1.
Egypt
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
13.4.3.1.1.
Targeted
Proteomics
13.4.3.1.2.
Biologics
characterization
13.4.3.1.3.
Metabolomics
13.4.3.1.4.
Multi-omics services
13.4.3.1.5.
Glycomics
Services
13.4.3.1.6.
Others
13.4.3.2.
Egypt
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
13.4.3.2.1.
Research
Centers Medical Device Companies
13.4.3.2.2.
Biopharmaceutical
and Pharmaceutical companies
13.4.3.2.3.
Medical
Device Companies
13.4.3.2.4.
Clinical
Diagnostics
13.4.3.2.5.
Others
13.4.4. Kuwait
13.4.4.1.
Kuwait
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
13.4.4.1.1.
Targeted
Proteomics
13.4.4.1.2.
Biologics
characterization
13.4.4.1.3.
Metabolomics
13.4.4.1.4.
Multi-omics services
13.4.4.1.5.
Glycomics
Services
13.4.4.1.6.
Others
13.4.4.2.
Kuwait
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
13.4.4.2.1.
Research
Centers Medical Device Companies
13.4.4.2.2.
Biopharmaceutical
and Pharmaceutical companies
13.4.4.2.3.
Medical
Device Companies
13.4.4.2.4.
Clinical
Diagnostics
13.4.4.2.5.
Others
13.4.5. South Africa
13.4.5.1.
South
Africa CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
13.4.5.1.1.
Targeted
Proteomics
13.4.5.1.2.
Biologics
characterization
13.4.5.1.3.
Metabolomics
13.4.5.1.4.
Multi-omics services
13.4.5.1.5.
Glycomics
Services
13.4.5.1.6.
Others
13.4.5.2.
South
Africa CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By End Users
13.4.5.2.1.
Research
Centers Medical Device Companies
13.4.5.2.2.
Biopharmaceutical
and Pharmaceutical companies
13.4.5.2.3.
Medical
Device Companies
13.4.5.2.4.
Clinical
Diagnostics
13.4.5.2.5.
Others
13.4.6. Rest of Middle East & Africa
13.4.6.1.
Rest of
Middle East & Africa CRO Mass Spectroscopy Services Market Revenue (US$ Mn) and Forecasts, By
Service Type
13.4.6.1.1.
Targeted
Proteomics
13.4.6.1.2.
Biologics
characterization
13.4.6.1.3.
Metabolomics
13.4.6.1.4.
Multi-omics services
13.4.6.1.5.
Glycomics
Services
13.4.6.1.6.
Others
13.4.6.2.
Rest of
Middle East & Africa CRO Mass Spectroscopy Services Market Revenue (US$ Mn) and Forecasts, By End
Users
13.4.6.2.1.
Research
Centers Medical Device Companies
13.4.6.2.2.
Biopharmaceutical
and Pharmaceutical companies
13.4.6.2.3.
Medical
Device Companies
13.4.6.2.4.
Clinical
Diagnostics
13.4.6.2.5.
Others
13.5. Key Segment for Channeling Investments
13.5.1. By Country
13.5.2. By Service Type
13.5.3. By End Users
14. Latin America CRO Mass Spectroscopy
Services Market Analysis and Forecasts, 2022
– 2030
14.1. Overview
14.1.1. Latin America CRO Mass Spectroscopy
Services Market Revenue (US$ Mn)
14.2. Latin America CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By Service Type
14.2.1. Targeted Proteomics
14.2.2. Biologics characterization
14.2.3. Metabolomics
14.2.4. Multi-omics services
14.2.5. Glycomics Services
14.2.6. Others
14.3. Latin America CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By End Users
14.3.1. Research Centers Medical Device Companies
14.3.2. Biopharmaceutical and Pharmaceutical
companies
14.3.3. Medical Device Companies
14.3.4. Clinical Diagnostics
14.3.5. Others
14.4. Latin America CRO Mass Spectroscopy
Services Market Revenue (US$ Mn) and
Forecasts, By Country
14.4.1. Brazil
14.4.1.1.
Brazil
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
14.4.1.1.1.
Targeted
Proteomics
14.4.1.1.2.
Biologics
characterization
14.4.1.1.3.
Metabolomics
14.4.1.1.4.
Multi-omics services
14.4.1.1.5.
Glycomics
Services
14.4.1.1.6.
Others
14.4.1.2.
Brazil
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
14.4.1.2.1.
Research
Centers Medical Device Companies
14.4.1.2.2.
Biopharmaceutical
and Pharmaceutical companies
14.4.1.2.3.
Medical
Device Companies
14.4.1.2.4.
Clinical
Diagnostics
14.4.1.2.5.
Others
14.4.2. Argentina
14.4.2.1.
Argentina
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
14.4.2.1.1.
Targeted
Proteomics
14.4.2.1.2.
Biologics
characterization
14.4.2.1.3.
Metabolomics
14.4.2.1.4.
Multi-omics services
14.4.2.1.5.
Glycomics
Services
14.4.2.1.6.
Others
14.4.2.2.
Argentina
CRO Mass Spectroscopy Services Market
Revenue (US$ Mn) and Forecasts, By End Users
14.4.2.2.1.
Research
Centers Medical Device Companies
14.4.2.2.2.
Biopharmaceutical
and Pharmaceutical companies
14.4.2.2.3.
Medical
Device Companies
14.4.2.2.4.
Clinical
Diagnostics
14.4.2.2.5.
Others
14.4.3. Rest of Latin America
14.4.3.1.
Rest of
Latin America CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
14.4.3.1.1.
Targeted
Proteomics
14.4.3.1.2.
Biologics
characterization
14.4.3.1.3.
Metabolomics
14.4.3.1.4.
Multi-omics services
14.4.3.1.5.
Glycomics
Services
14.4.3.1.6.
Others
14.4.3.2.
Rest of
Latin America CRO Mass Spectroscopy Services
Market Revenue (US$ Mn) and Forecasts, By End Users
14.4.3.2.1.
Research
Centers Medical Device Companies
14.4.3.2.2.
Biopharmaceutical
and Pharmaceutical companies
14.4.3.2.3.
Medical
Device Companies
14.4.3.2.4.
Clinical
Diagnostics
14.4.3.2.5.
Others
14.5. Key Segment for Channeling Investments
14.5.1. By Country
14.5.2. By Service Type
14.5.3. By End Users
15. Competitive Benchmarking
15.1. Brand Benchmarking
15.2. Market Share Analysis, 2020
15.3. Global Presence and Growth Strategies
15.3.1. Mergers and Acquisitions
15.3.2. Product Launches
15.3.3. Investments Trends
15.3.4. R&D Initiatives
16. Player Profiles
16.1. Alphalyse
16.1.1. Company Details
16.1.2. Company Overview
16.1.3. Product Offerings
16.1.4. Key Developments
16.1.5. Financial Analysis
16.1.6. SWOT Analysis
16.1.7. Business Strategies
16.2. Altasciences
16.2.1. Company Details
16.2.2. Company Overview
16.2.3. Product Offerings
16.2.4. Key Developments
16.2.5. Financial Analysis
16.2.6. SWOT Analysis
16.2.7. Business Strategies
16.3. Alturas Analytics.
16.3.1. Company Details
16.3.2. Company Overview
16.3.3. Product Offerings
16.3.4. Key Developments
16.3.5. Financial Analysis
16.3.6. SWOT Analysis
16.3.7. Business Strategies
16.4. AxisPharm
16.4.1. Company Details
16.4.2. Company Overview
16.4.3. Product Offerings
16.4.4. Key Developments
16.4.5. Financial Analysis
16.4.6. SWOT Analysis
16.4.7. Business Strategies
16.5. BGI
16.5.1. Company Details
16.5.2. Company Overview
16.5.3. Product Offerings
16.5.4. Key Developments
16.5.5. Financial Analysis
16.5.6. SWOT Analysis
16.5.7. Business Strategies
16.6. biocrates inc.
16.6.1. Company Details
16.6.2. Company Overview
16.6.3. Product Offerings
16.6.4. Key Developments
16.6.5. Financial Analysis
16.6.6. SWOT Analysis
16.6.7. Business Strategies
16.7. Biognosys Inc
16.7.1. Company Details
16.7.2. Company Overview
16.7.3. Product Offerings
16.7.4. Key Developments
16.7.5. Financial Analysis
16.7.6. SWOT Analysis
16.7.7. Business Strategies
16.8. Biolabs Inc
16.8.1. Company Details
16.8.2. Company Overview
16.8.3. Product Offerings
16.8.4. Key Developments
16.8.5. Financial Analysis
16.8.6. SWOT Analysis
16.8.7. Business Strategies
16.9. Charles River Laboratories
16.9.1. Company Details
16.9.2. Company Overview
16.9.3. Product Offerings
16.9.4. Key Developments
16.9.5. Financial Analysis
16.9.6. SWOT Analysis
16.9.7. Business Strategies
16.10. Creative Proteomics.
16.10.1. Company Details
16.10.2. Company Overview
16.10.3. Product Offerings
16.10.4. Key Developments
16.10.5. Financial Analysis
16.10.6. SWOT Analysis
16.10.7. Business Strategies
16.11. Eurofins Scientific
16.11.1. Company Details
16.11.2. Company Overview
16.11.3. Product Offerings
16.11.4. Key Developments
16.11.5. Financial Analysis
16.11.6. SWOT Analysis
16.11.7. Business Strategies
16.12. Evotec SE
16.12.1. Company Details
16.12.2. Company Overview
16.12.3. Product Offerings
16.12.4. Key Developments
16.12.5. Financial Analysis
16.12.6. SWOT Analysis
16.12.7. Business Strategies
16.13. LiVeritas Biosciences, Inc.
16.13.1. Company Details
16.13.2. Company Overview
16.13.3. Product Offerings
16.13.4. Key Developments
16.13.5. Financial Analysis
16.13.6. SWOT Analysis
16.13.7. Business Strategies
16.14. MS Bioworks
16.14.1. Company Details
16.14.2. Company Overview
16.14.3. Product Offerings
16.14.4. Key Developments
16.14.5. Financial Analysis
16.14.6. SWOT Analysis
16.14.7. Business Strategies
16.15. NorthEast BioAnalytical Laboratories LLC.
16.15.1. Company Details
16.15.2. Company Overview
16.15.3. Product Offerings
16.15.4. Key Developments
16.15.5. Financial Analysis
16.15.6. SWOT Analysis
16.15.7. Business Strategies
16.16. Novatia, LLC
16.16.1. Company Details
16.16.2. Company Overview
16.16.3. Product Offerings
16.16.4. Key Developments
16.16.5. Financial Analysis
16.16.6. SWOT Analysis
16.16.7. Business Strategies
16.17. PPD Inc
16.17.1. Company Details
16.17.2. Company Overview
16.17.3. Product Offerings
16.17.4. Key Developments
16.17.5. Financial Analysis
16.17.6. SWOT Analysis
16.17.7. Business Strategies
16.18. Protagen Protein Services GmbH
16.18.1. Company Details
16.18.2. Company Overview
16.18.3. Product Offerings
16.18.4. Key Developments
16.18.5. Financial Analysis
16.18.6. SWOT Analysis
16.18.7. Business Strategies
16.19. Waters Corporation
16.19.1. Company Details
16.19.2. Company Overview
16.19.3. Product Offerings
16.19.4. Key Developments
16.19.5. Financial Analysis
16.19.6. SWOT Analysis
16.19.7. Business Strategies
17. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.